Alpha Tau Medical Ltd (DRTS)

$10.41

up-down-arrow $0.77 (7.99%)

As on 14-May-2026 16:25EDT

Market cap

info icon

$910 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

9.7

Div. Yield

info icon

0 %

Value Research Rating

--

Quality Score fund-quick-summary-circle

Quality Score/10

Growth Score fund-quick-summary-circle

Growth Score/10

Valuation Score fund-quick-summary-circle

Valuation Score/10

Momentum Score fund-quick-summary-circle

Momentum Score/10

Alpha Tau Medical (DRTS) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Stock Range

Today’s Range

Low: 9.45 High: 10.50

52 Week Range

Low: 2.78 High: 10.80

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.6 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -4.8

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    88,009,737

5 Years Aggregate

CFO

$-67.81 Mln

EBITDA

$-94.70 Mln

Net Profit

$-107.54 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Alpha Tau Medical (DRTS)
110.3 36.3 44.4 277.2 39.1 1.5 --
BSE Sensex*
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
As on 14-May-2026  |  *As on 15-May-2026
Company
2025
2023
Alpha Tau Medical (DRTS)
59.7 -5.3
BSE Sensex
9.1 18.7
BSE Sensex
9.1 18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

*All values are in ($ Mln)

*All values are in ($ Mln)

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT...  technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel. Address: Kiryat HaMada St. 5, Jerusalem, Israel, 9777605  Read more

Edit peer-selector-edit

FAQs for Alpha Tau Medical (DRTS)

The share price of Alpha Tau Medical Ltd (DRTS) is $10.41 (NASDAQ) as of 14-May-2026 16:25 EDT. Alpha Tau Medical Ltd (DRTS) has given a return of 39.07% in the last 3 years.

Since, TTM earnings of Alpha Tau Medical Ltd (DRTS) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
--
--
2024
--
--
2023
--
--
2022
-6.03
1.93
2021
-14.76
-11.58

The 52-week high and low of Alpha Tau Medical Ltd (DRTS) are Rs 10.80 and Rs 2.78 as of 15-May-2026.

Alpha Tau Medical Ltd (DRTS) has a market capitalisation of $ 910 Mln as on 12-May-2026. As per SEBI classification, it is a company.

Before investing in Alpha Tau Medical Ltd (DRTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.